{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:45Z","timestamp":1772165625975,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03522-2","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T01:48:50Z","timestamp":1732499330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of past extensive ulcers on fecal calprotectin in ulcerative colitis"],"prefix":"10.1186","volume":"24","author":[{"given":"Natsuki","family":"Ishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Egami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Takebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Yamade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moriya","family":"Iwaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Hamaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"3522_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Acosta MB, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649\u201370. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx008.","journal-title":"J Crohns Colitis"},{"key":"3522_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF02556166","volume":"30","author":"JK Kelly","year":"1987","unstructured":"Kelly JK, Gabos S. The pathogenesis of inflammatory polyps. Dis Colon Rectum. 1987;30:251\u20134. https:\/\/doi.org\/10.1007\/BF02556166.","journal-title":"Dis Colon Rectum"},{"key":"3522_CR3","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3748\/wjg.v23.i9.1541","volume":"23","author":"DS Politis","year":"2017","unstructured":"Politis DS, Katsanos KH, Tsianos EV, Christodoulou DK. Pseudopolyps in inflammatory bowel diseases: have we learned enough? World J Gastroenterol. 2017;23:1541\u201351. https:\/\/doi.org\/10.3748\/wjg.v23.i9.1541.","journal-title":"World J Gastroenterol"},{"key":"3522_CR4","doi-asserted-by":"publisher","first-page":"167sr1","DOI":"10.1126\/scitranslmed.3004700","volume":"5","author":"SL Friedman","year":"2013","unstructured":"Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med. 2013;5:167sr1. https:\/\/doi.org\/10.1126\/scitranslmed.3004700.","journal-title":"Sci Transl Med"},{"key":"3522_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrgastro.2009.31","volume":"6","author":"F Rieder","year":"2009","unstructured":"Rieder F, Fiocchi C. Intestinal fibrosis in IBD\u2014a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol. 2009;6:228\u201335. https:\/\/doi.org\/10.1038\/nrgastro.2009.31.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3522_CR6","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A, D\u2019Amico F, Kotze PG, Yoshida EM, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160:1570\u201383. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.031.","journal-title":"Gastroenterology"},{"key":"3522_CR7","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/ibd.20986","volume":"15","author":"AM Schoepfer","year":"2009","unstructured":"Schoepfer AM, Beglinger C, Straumann A, Safroneeva E, Romero Y, Armstrong D, et al. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis. 2009;15:1851\u20138. https:\/\/doi.org\/10.1002\/ibd.20986.","journal-title":"Inflamm Bowel Dis"},{"key":"3522_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/ajg.2012.315","volume":"108","author":"A Nakarai","year":"2013","unstructured":"Nakarai A, Kato J, Hiraoka S, Kuriyama M, Akita M, Hirakawa T, et al. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test. Am J Gastroenterol. 2013;108:83\u20139. https:\/\/doi.org\/10.1038\/ajg.2012.315.","journal-title":"Am J Gastroenterol"},{"key":"3522_CR9","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.3748\/wjg.v22.i21.5079","volume":"22","author":"A Nakarai","year":"2016","unstructured":"Nakarai A, Kato J, Hiraoka S, Kuriyama M, Akita M, Hirakawa T, et al. Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse. World J Gastroenterol. 2016;22:5079\u201387. https:\/\/doi.org\/10.3748\/wjg.v22.i21.5079.","journal-title":"World J Gastroenterol"},{"key":"3522_CR10","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ajg.2015.66","volume":"110","author":"S Takashima","year":"2015","unstructured":"Takashima S, Kato J, Hiraoka S, Nakarai A, Takei D, Inokuchi T, et al. Evaluation of mucosal healing in ulcerative colitis by fecal calprotectin vs. fecal immunochemical test. Am J Gastroenterol. 2015;110:873\u201380. https:\/\/doi.org\/10.1038\/ajg.2015.66.","journal-title":"Am J Gastroenterol"},{"key":"3522_CR11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/MIB.0000000000000736","volume":"22","author":"K Theede","year":"2016","unstructured":"Theede K, Holck S, Ibsen P, Kallemose T, Nordgaard-Lassen I, Nielsen AM. Fecal calprotectin predicts relapse and histological mucosal healing in ulcerative colitis. Inflamm Bowel Dis. 2016;22:1042\u20138. https:\/\/doi.org\/10.1097\/MIB.0000000000000736.","journal-title":"Inflamm Bowel Dis"},{"key":"3522_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/ecco-jcc\/jjw025","volume":"10","author":"S Hiraoka","year":"2016","unstructured":"Hiraoka S, Kato J, Nakarai A, Kuriyama M, Akita M, Hirakawa T, et al. Consecutive measurements by faecal immunochemical test in quiescent ulcerative colitis patients can detect clinical relapse. J Crohns Colitis. 2016;10:687\u201394. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw025.","journal-title":"J Crohns Colitis"},{"key":"3522_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"D Rachmilewitz","year":"1989","unstructured":"Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J. 1989;298:82\u20136. https:\/\/doi.org\/10.1136\/bmj.298.6666.82.","journal-title":"Br Med J"},{"key":"3522_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625\u20139. https:\/\/doi.org\/10.1056\/NEJM198712243172603.","journal-title":"N Engl J Med"},{"key":"3522_CR15","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transpl"},{"key":"3522_CR16","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.crohns.2014.03.009","volume":"8","author":"F Rieder","year":"2014","unstructured":"Rieder F, de Bruyn JR, Pham BT, Remzi FH, Ferrante M, Oresland T, et al. Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease. J Crohns Colitis. 2014;8:1166\u201378. https:\/\/doi.org\/10.1016\/j.crohns.2014.03.009.","journal-title":"J Crohns Colitis"},{"key":"3522_CR17","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1097\/MIB.0000000000000080","volume":"20","author":"IO Gordon","year":"2014","unstructured":"Gordon IO, Agrawal N, Goldblum JR, Rieder F, Fiocchi C. Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem. Inflamm Bowel Dis. 2014;20:2198\u2013206. https:\/\/doi.org\/10.1097\/MIB.0000000000000080.","journal-title":"Inflamm Bowel Dis"},{"key":"3522_CR18","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/ecco-jcc\/jjv133","volume":"9","author":"JR de Bruyn","year":"2015","unstructured":"de Bruyn JR, Meijer SL, Wildenberg ME, Peppelenbosch MP, van den Brink GR, D\u2019Haens GR, et al. Development of fibrosis in acute and longstanding ulcerative colitis. J Crohns Colitis. 2015;9:966\u201372. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv133.","journal-title":"J Crohns Colitis"},{"key":"3522_CR19","first-page":"892","volume":"84","author":"V Loening-Baucke","year":"1989","unstructured":"Loening-Baucke V, Metcalf AM, Shirazi S. Anorectal manometry in active and quiescent ulcerative colitis. Am J Gastroenterol. 1989;84:892\u20137.","journal-title":"Am J Gastroenterol"},{"key":"3522_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051122","volume":"10","author":"A Derkacz","year":"2021","unstructured":"Derkacz A, Olczyk P, Olczyk K, Komosinska-Vassev K. The role of extracellular matrix components in inflammatory bowel diseases. J Clin Med. 2021;10: 1122. https:\/\/doi.org\/10.3390\/jcm10051122.","journal-title":"J Clin Med"},{"key":"3522_CR21","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nchembio.1891","volume":"11","author":"TG Nakashige","year":"2015","unstructured":"Nakashige TG, Zhang B, Krebs C, Nolan EM. Human calprotectin is an iron-sequestering host-defense protein. Nat Chem Biol. 2015;11:765\u201371. https:\/\/doi.org\/10.1038\/nchembio.1891.","journal-title":"Nat Chem Biol"},{"key":"3522_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/ecco-jcc\/jjaa093","volume":"15","author":"F D\u2019Amico","year":"2021","unstructured":"D\u2019Amico F, Nancey S, Danese S, Peyrin-Biroulet L. A practical guide for faecal calprotectin measurement: myths and realities. J Crohns Colitis. 2021;15:152\u201361. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa093.","journal-title":"J Crohns Colitis"},{"key":"3522_CR23","first-page":"371","volume":"63","author":"KP Geboes","year":"2000","unstructured":"Geboes KP, Cabooter L, Geboes K. Contribution of morphology for the comprehension of mechanisms of fibrosis in inflammatory enterocolitis. Acta Gastroenterol Belg. 2000;63:371\u20136.","journal-title":"Acta Gastroenterol Belg"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03522-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03522-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03522-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T02:02:02Z","timestamp":1732500122000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03522-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3522"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03522-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4868028\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Ethics Committee of Hamamatsu University School of Medicine (number 23\u2013327). This study was conducted in accordance with the principles of Good Clinical Practice outlined in the Declaration of Helsinki. Informed consent was obtained in the form of an opt-out on the hospital website.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"426"}}